Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
about
Clostridium difficile associated diarrhoea: diagnosis and treatment.Bench-to-bedside review: Clostridium difficile colitisComparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsRecent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionRecent advances in the understanding of antibiotic resistance in Clostridium difficile infectionProbiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseasesClostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic reviewClostridium difficile Infection in Children: Current State and Unanswered QuestionsRisk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewRecent changes in Clostridium difficile infectionAntimicrobial safety: focus on fluoroquinolonesMolecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in ThailandTrends in Clostridium difficile Disease: Epidemiology and InterventionPrediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic reviewClostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventionsThe changing epidemiology of Clostridium difficile infectionsInterspecies Interactions between Clostridium difficile and Candida albicansSuccessful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case reportAutomated surveillance of Clostridium difficile infections using BioSense.Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile infection: Updates in management.Clostridium difficile infection: New insights into therapeutic options.The microbiota and immune response during Clostridium difficile infection.Glutamine and alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-a-induced intestinal epithelial cell damageEffects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains.Surveillance of prescription drug-related mortality using death certificate data.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Clostridium difficile ribotype 027, toxinotype III, the Netherlands.Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.Clinical review of the management of fulminant clostridium difficile infection.Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin APrevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic reviewPrevalence of diverticulosis in recurrent Clostridium difficile infectionClostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Multilocus sequence typing of Clostridium difficileRisk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.Analysis of ultra low genome conservation in Clostridium difficile.
P2860
Q24531456-19403FC4-12CB-458D-AEEB-3A72155370CEQ24644191-C13B6BF9-2D09-4F8E-A286-B1F488EA4F35Q26752760-B6536390-B85D-4F18-8764-8B283458A075Q26766112-6E15DDB1-0644-4C05-A488-E0275346281FQ26767079-4D5BE88E-9802-44B4-93DB-AA28D5654A43Q26800020-5246E137-9E7B-4EB6-BF19-E8ED96FD99F5Q26827693-7A51ADFD-DB56-4A40-B306-6D81682A2830Q27016320-C4127D5A-F1EB-448F-BFF8-C3C2DCE8358CQ27021390-01560D9B-F33F-40D9-A598-D4E7193B9890Q27022537-7535F9F1-BBC0-4DEC-B126-BCAD4E2F8ADCQ28255152-68B2CA7B-CF32-4F31-B150-212229C3738AQ28547441-76E7EF4F-4CD7-472A-97D7-BC8E91C638A3Q28655729-CE7F3A28-7A60-4550-810C-E5F6EC9AA1C5Q28732437-984F95DA-5999-4521-8FB2-FDDE0CC55232Q28743438-F33BA70F-B342-47D6-A972-6737C117B78EQ28750385-0AD3792D-C03A-4E00-A404-2A35EDA0F322Q28821706-E667754B-3299-4A72-8529-0AC69AAFA196Q28828482-683D8E94-85D1-4BD0-B5FC-74F25A825D15Q30226865-EBAAFCEA-96B4-457F-9837-8C3510AF5E97Q30229124-F4BCBFDC-C8F6-4360-BB4E-909E21855E8FQ30235905-EC7F7ED6-A543-4BED-ABE6-648070BC244CQ30239988-D604318A-2716-4808-B5CE-AD089156C337Q30252154-BD87EB7B-9DC8-4D87-A2A1-C19BE26E0C2EQ30276756-E7EDD769-54B1-4A42-AA96-F75774B7C2F2Q30421944-7281E0CD-C6A0-442B-BEA4-4DBA214290C8Q30427422-7782C50A-EA95-43EA-808C-9453076702CDQ30434665-5395C2EB-80EB-4002-A6CB-70B50177C2C6Q30475404-FCB2ADD5-172D-4A66-88D1-62750C0CFB96Q31114133-1BBD4474-00B8-4CA2-8670-27A3F479CA7AQ33214954-14E97BE4-43F6-498E-8AEC-B8A51B580A8EQ33243642-10E858ED-602A-4A64-8B76-711A97A50868Q33276804-F4A9042F-2893-4952-883B-36374D585FBCQ33375824-C8D4BB2E-059B-4126-BAA2-979830CBB958Q33475206-EDB7331C-2790-4D44-A633-28F19F480F5EQ33518583-891D1DF4-B435-4F45-8371-3D187221F3C0Q33596510-40D859C1-00B8-44B9-9D8C-C2555905D95DQ33603104-3B4BE1F9-62DD-4DDD-9928-927608FCA17AQ33704701-FB4444E4-366A-47C3-A110-7D74CDEBCF1FQ33729925-16E871CC-638D-4FC8-BE6F-066BEDBDBF1EQ33775602-6D87F543-60A5-432D-BBAE-8FA0912BD846
P2860
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clostridium difficile-associat ...... g pattern of disease severity.
@ast
Clostridium difficile-associat ...... g pattern of disease severity.
@en
type
label
Clostridium difficile-associat ...... g pattern of disease severity.
@ast
Clostridium difficile-associat ...... g pattern of disease severity.
@en
prefLabel
Clostridium difficile-associat ...... g pattern of disease severity.
@ast
Clostridium difficile-associat ...... g pattern of disease severity.
@en
P2093
P2860
P356
P1476
Clostridium difficile-associat ...... g pattern of disease severity.
@en
P2093
Annick Pelletier
Daniel Chouinard
Jacques Pépin
Karine Forget
Karine Pépin
Marie-Eve Alary
Philippe Villemure
P2860
P304
P356
10.1503/CMAJ.1041104
P407
P577
2004-08-01T00:00:00Z